Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Changchun High-Tech Industry (Group) Co FCF Margin % Chart
Changchun High-Tech Industry (Group) Co Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Changchun High-Tech Industry (Group) Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Changchun High-Tech Industry (Group) Co FCF Margin % vs Drug Manufacturers Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Changchun High-Tech Industry (Group) Co (SZSE:000661) has a FCF Margin % of 12.19% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Changchun High-Tech Industry (Group) Co and its competitors. This is 142% above median its historical median of 5.03. According to the industry distribution chart, Changchun High-Tech Industry (Group) Co ranks #665 out of 963 companies in the Drug Manufacturers industry, placing it in the top 69.1%.
Is Changchun High-Tech Industry (Group) Co's FCF Margin % too high?
Changchun High-Tech Industry (Group) Co's current FCF Margin % of 12.19% is 142% above median its 10-year median of 5.03. The Drug Manufacturers industry median FCF Margin % is 2.78. Changchun High-Tech Industry (Group) Co's value of 12.19% is 338.5% above this industry median. Based on the distribution chart, Changchun High-Tech Industry (Group) Co ranks #665 out of 963 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Changchun High-Tech Industry (Group) Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Changchun High-Tech Industry (Group) Co's FCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Changchun High-Tech Industry (Group) Co ranks #665 out of 963 companies for FCF Margin %. This places Changchun High-Tech Industry (Group) Co in the lower half of its industry. The industry median FCF Margin % is 2.78. Changchun High-Tech Industry (Group) Co's value of 12.19% is 338.5% above this benchmark. While the company's 10-year median is 5.03 vs. the industry median of 2.78, Changchun High-Tech Industry (Group) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.78, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Changchun High-Tech Industry (Group) Co's current FCF Margin % of 12.19% is 338.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Changchun High-Tech Industry (Group) Co and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Changchun High-Tech Industry (Group) Co's current FCF Margin % is 12.19%, which is 142% above median its own 10-year median of 5.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Changchun High-Tech Industry (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Changchun High-Tech Industry (Group) Co (SZSE:000661) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥85.96, compared to a current price of ¥74.76 — trading 13% below its estimated fair value. The current FCF Margin % is 12.19%, which is 142% above median its 10-year median of 5.03 and 338.5% above the Drug Manufacturers industry median of 2.78. Changchun High-Tech Industry (Group) Co's overall GF Score™ is 84/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Changchun High-Tech Industry (Group) Co (SZSE:000661), the current FCF Margin % is 12.19% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Changchun High-Tech Industry (Group) Co (SZSE:000661) Overvalued in 2026?
Based on GuruFocus' analysis, Changchun High-Tech Industry (Group) Co stock appears to be undervalued.
The current stock price of ¥74.76 is trading 13% below its estimated GF Value™ of ¥85.96.
GuruFocus considers Changchun High-Tech Industry (Group) Co to be Modestly Undervalued.
Key valuation signals for SZSE:000661:
FCF Margin %: 12.19% (142% above median its 10-year median of 5.03)
GF Value™: ¥85.96 vs. price of ¥74.76 (13% below fair value)
Industry Position: 338.5% above the Drug Manufacturers median (#665 of 963)
No single metric tells the full story. See the SZSE:000661 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Changchun High-Tech Industry (Group) Co Ltd is engaged in the production and sales of biopharmaceuticals, Chinese patent medicine production, and real estate development. The company operates its business through three segments. The Pharmaceuticals segment focuses on the research and development, manufacturing, and sales of genetically engineered biologics, human vaccines, traditional Chinese medicines, and chemical pharmaceuticals. The Real Estate segment is involved in property development and sales. The Services segment provides scientific research and technical support, along with leasing and various business-related services. It generates the majority of its revenue from the Pharmaceuticals segment.
84GF Score
Get the complete analysis for SZSE:000661
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:000661 has been successfully added to your 
